Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Roger Pomerantz currently holds 18,069 shares of Viracta Therapeutics, Inc. (VIRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roger Pomerantz has been a net seller of VIRX stock. They have purchased $3.3K and sold $19.6M worth of shares.
Roger Pomerantz's most recent insider trade was on Nov 25, 2024, when they sold 9,034 shares at $0.00 per share.
Roger Pomerantz serves as Executive at Viracta Therapeutics, Inc. (VIRX). They have executed 101 insider transactions totaling $19.6M over their tenure at the company.
Roger Pomerantz holds the position of Executive at Viracta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Roger Pomerantz has shown a selling trading pattern, with $3.3K in total purchases and $19.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Roger Pomerantz was on Jul 27, 2016, when they sold $700.0K worth of MCRB shares. This transaction involved 20,000 shares at $35.00 per share.
Roger Pomerantz currently owns 18,069 shares of Viracta Therapeutics, Inc. (VIRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Roger Pomerantz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Roger Pomerantz has 101 Form 4 filings on record as an insider at Viracta Therapeutics, Inc..
Set alerts for Roger Pomerantz and 40,000+ other insiders.